Plasma retinol: a novel marker for cardiovascular disease mortality in Australian adults

Laima Brazionis, Karen Zell Walker, Catherine Itsiopoulos, Kerin O'Dea

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

Background and aims: Vitamin A affects inflammation and immune function and is thus a factor of interest in relation to cardiovascular disease (CVD). As vitamin A circulates in the plasma in the form of retinol, this study aims to describe the relationship between plasma retinol and the 5-year incidence of CVD mortality. Methods and results: Community-dwelling adults (n Z 441, 45 with type 2 diabetes) were recruited in Melbourne, assessed at baseline and followed for 5 years. At baseline, CVD risk factors were assessed by clinical evaluation, by personal lifestyle questionnaire and from biochemistry (plasma fasting glucose, lipids, total homocysteine, C-reactive protein, retinol and carotenoids plus the urinary albumin excretion rate over 24 h.). Dietary intake was assessed by a validated food frequency questionnaire. CVD mortality over 5-years was determined by consulting state or national registries. The majority of participants had adequate plasma retinol concentrations ( 30 mg/dL). The final Cox regression model indicated that those in the highest tertile of plasma retinol (mean SD) 76 14 mg/dL) had a significantly lower risk of 5-year CVD mortality (hazard ratio 0.27 [95 confidence interval 0.11, 0.68], P Z 0.005), an effect that was not readily explained in terms of traditional CVD risk factors or dietary intake. Conclusion: In well-nourished older Australian adults, plasma retinol was inversely associated with CVD mortality via mechanisms apparently unrelated to established CVD risk factors and dietary intake.
Original languageEnglish
Pages (from-to)914 - 920
Number of pages7
JournalNutrition Metabolism and Cardiovascular Diseases
Volume22
Issue number10
DOIs
Publication statusPublished - 2012

Cite this